Support and advocacy groups can help you connect with other patients and families, and they can provide valuable services. Many develop patient-centered information and are the driving force behind research for better treatments and possible cures. They can direct you to research, resources, and services. Many organizations also have experts who serve as medical advisors or provide lists of doctors/clinics. Visit the group’s website or contact them to learn about the services they offer. Inclusion on this list is not an endorsement by GARD.
Living with a genetic or rare disease can impact the daily lives of patients and families. These resources can help families navigate various aspects of living with a rare disease.
These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.
Don’t Miss the NCATS Toolkit for Patient-Focused Therapy Development Event
August 31, 2017
Funding Opportunities Now Available for the Undiagnosed Diseases Network (UDN) Phase II
August 30, 2017
IRDiRC Goals 2017-2027: New Rare Disease Research Goals for the Next Decade
August 10, 2017
Advancing Symptom Clusters Research on Rare Cancers Wednesday, June 17, 2015
Location: NIH Neuroscience Building,
Bethesda,
MD
Description:
It is intended that the in-depth, interdisciplinary dialogue of this expert working group will formulate an emerging consensus on a working definition of symptom clusters and, specific gaps and opportunities that provide a foundation for a transformative strategic blueprint to guide future symptom cluster research in rare cancers. In addition, it is anticipated that workshop proceedings will inform a funding opportunity announcement.
Contact: Sue Marden, Ph.D.,(301) 496-9623,mardens@mail.nih.gov
Co-funding Institute(s): National Institute of Nursing Research, Office of Rare Diseases Research
Genetic Diseases of Children: Advancing Research & Care
Monday, March 7, 2011 -
Wednesday, March 9, 2011
Location: Sheraton New York Hotel & Towers,
New York,
NY
Description: The New York State Department of Health announced Genetic Diseases of Children: Advancing Research & Care. This national conference brought together the worlds of health, science, government, and industry with the families who look to them for answers.
Contact: Janet B. Braga, NYS Department of Health,(518) 473-8022gdcconference@wadsworth.org
Co-funding Institute(s): Other, Office of Rare Diseases Research
Overcoming Barriers to International Clinical Trials for Rare Cancers
Friday, December 10, 2010
Location:
Bethesda,
Maryland
Description: The goals of this conference were to introduce key institutional players to the topic of international clinical trials in rare cancers and to establish an ongoing dialogue. Participants left the meeting with a set of specific priorities that need to be enacted to promote these trials. The meeting promoted consensus on the way that resources are prioritized to address rare cancers. Participants were asked to convey the content of the meeting to their constituencies and to follow up with pilot concepts.
Contact: Jack Welch, M.D., Ph.D., jack.welch@nih.govjack.welch@nih.gov
Co-funding Institute(s): National Cancer Institute, Office of Rare Diseases Research
Workshop on the Etiology of Hepatocellular Carcinoma in the United States Saturday, April 17, 2010
Location: Embassy Suites Hotel - DC Convention Center,
Washington,
DC
Description: The goal of this workshop was to assemble investigators of U.S.-based cohort studies in order to form a hepatocellular carcinoma (HCC) pooling project.
Contact: Dr. Katherine A. McGlynn, NCI(301) 435-4918mcglynnk@mail.nih.gov
Co-funding Institute(s): National Cancer Institute, Office of Rare Diseases Research
Second International Workshop on Cholangiocarcinoma and Hepatocellular Carcinoma
Tuesday, October 6, 2009 -
Wednesday, October 7, 2009
Location: Natcher Conference Ctr., NIH Campus,
Bethesda,
MD
Description: The objective of this workshop was to bring together basic researchers, clinicians, epidemiologists, and bioinformaticians worldwide who are experts in liver cancer biology and genetics study to exchange state-of-the-art and late-breaking discoveries. This meeting provided a forum for both intramural and extramural scientists for a better understanding of the latest research findings and implementation of these findings in diagnosis, treatment, and prevention of liver cancer. This meeting also promoted awareness of liver cancer research to the intramural community.
Contact: Dr. Xin Wei Wang, NCI301-496-2099
Co-funding Institute(s): National Cancer Institute
The following diseases are related to Primary liver cancer. If you have a question about any of these diseases, you can contact GARD.
Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know.